Location History:
- Scio, MI (US) (2007)
- Ann Arbor, MI (US) (1989 - 2014)
- East Lansing, MI (US) (2020)
Company Filing History:
6 out of 3,381 
2 out of 1,415 
1 out of 48 
Years Active: 1989-2020
Title: Richard Neubig: A Pioneer in Gene Transcription Inhibitors
Introduction
Richard Neubig is a prominent inventor based in East Lansing, Michigan, with a strong focus on innovative solutions in the field of biotechnology and medicine. With a total of five patents to his name, Richard is recognized for his groundbreaking contributions to the understanding and treatment of various diseases, including cancer and fibrosis.
Latest Patents
Among his most recent inventions are a series of patents that target Rho/MRTF/SRF-mediated gene transcription. The first patent discloses inhibitors designed to block this pathway, offering potential methods for preventing and treating diseases such as cancer and fibrosis. The compounds outlined in the patent are of Formula (I) and their pharmaceutically acceptable salts.
Furthermore, his second related patent similarly focuses on inhibitors of myocardin-related transcription factor and serum response factor (MRTF/SRF)-mediated gene transcription. These inventions aim to address the same clinical issues and include compounds of both Formula (I) and Formula (II), along with their respective pharmaceutically acceptable salts.
Career Highlights
Richard Neubig has had an illustrious career, during which he has held positions within reputable institutions such as the University of Michigan and Michigan State University. His work in these prestigious establishments has paved the way for significant advancements in gene therapy and transcription regulation.
Collaborations
Throughout his career, Richard has collaborated with talented individuals, including Scott D. Larsen and Kim Hutchings. These partnerships have greatly contributed to the depth and success of his research and innovations, fostering a collaborative environment in scientific inquiry.
Conclusion
Richard Neubig stands out as a significant figure in the realm of biotechnology, especially in the context of gene transcription modulation. His innovative patents reflect his dedication to developing new therapeutic strategies, ultimately enhancing treatment possibilities for serious health conditions. Richard's contributions continue to inspire advancements in medical research and biotechnology.